SecSonar.com

Precision BioSciences, Inc. (DTIL)

Precision BioSciences, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Precision BioSciences, Inc. (DTIL) is a Biotechnology company based in US with a market capitalization of $89.5M. Revenue declined 50.1% year-over-year and free cash flow was negative at -$65.9M. This page tracks DTIL's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 108 employees · IPO Mar 28, 2019

Valuation

Valuation & price

$7.27 · as of May 17, 2026 · -15.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.97

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$8.43$6.11$3.79Jul 25Dec 25Jul 26Jul 7, 25$4.31Jul 9, 25$4.73Jul 11, 25$4.45Jul 15, 25$4.45Jul 17, 25$4.64Jul 21, 25$4.65Jul 23, 25$4.94Jul 25, 25$5.15Jul 29, 25$4.89Jul 31, 25$4.75Aug 4, 25$4.84Aug 6, 25$4.81Aug 11, 25$4.35Aug 13, 25$4.69Aug 15, 25$4.71Aug 19, 25$4.80Aug 21, 25$4.74Aug 25, 25$5.13Aug 27, 25$5.01Aug 29, 25$4.90Sep 3, 25$5.05Sep 5, 25$5.07Sep 9, 25$5.09Sep 11, 25$5.00Sep 16, 25$4.67Sep 18, 25$4.91Sep 22, 25$4.86Sep 24, 25$5.13Sep 26, 25$5.06Sep 30, 25$5.52Oct 2, 25$5.42Oct 6, 25$5.67Oct 8, 25$5.70Oct 10, 25$5.62Oct 14, 25$5.85Oct 16, 25$6.64Oct 21, 25$6.99Oct 23, 25$6.93Oct 27, 25$7.18Oct 29, 25$8.43Oct 31, 25$8.16Nov 4, 25$6.69Nov 6, 25$6.44Nov 10, 25$6.07Nov 12, 25$6.00Nov 14, 25$5.88Nov 18, 25$5.22Nov 20, 25$4.98Nov 25, 25$4.88Nov 28, 25$5.44Dec 2, 25$4.79Dec 4, 25$5.02Dec 8, 25$4.76Dec 10, 25$5.01Dec 12, 25$4.99Dec 16, 25$4.82Dec 18, 25$4.52Dec 22, 25$4.34Dec 24, 25$4.29Dec 29, 25$4.30Jan 2, 26$4.10Jan 6, 26$4.21Jan 8, 26$4.03Jan 12, 26$4.06Jan 14, 26$4.13Jan 16, 26$4.05Jan 21, 26$4.01Jan 23, 26$4.20Jan 27, 26$4.13Jan 29, 26$3.99Feb 2, 26$3.98Feb 4, 26$3.83Feb 9, 26$3.81Feb 11, 26$4.07Feb 13, 26$3.89Feb 18, 26$3.85Feb 20, 26$3.79Feb 24, 26$4.00Feb 26, 26$3.99Mar 2, 26$4.33Mar 4, 26$4.77Mar 6, 26$4.61Mar 10, 26$5.35Mar 12, 26$5.67Mar 17, 26$6.93Mar 19, 26$6.72Mar 23, 26$6.52Mar 25, 26$6.47Mar 27, 26$6.02Mar 31, 26$5.50Apr 2, 26$5.82Apr 7, 26$6.26Apr 9, 26$6.61Apr 13, 26$7.13Apr 15, 26$7.66Apr 17, 26$7.88Apr 22, 26$7.91Apr 24, 26$7.04Apr 28, 26$7.10Apr 30, 26$7.15May 4, 26$7.63May 6, 26$7.52May 8, 26$7.69May 12, 26$8.20May 14, 26$8.11May 18, 26$6.96May 20, 26$7.18May 22, 26$7.23May 28, 26$6.92Jun 1, 26$7.02Jun 3, 26$6.04Jun 5, 26$6.50Jun 9, 26$6.86Jun 11, 26$6.17Jun 15, 26$6.21Jun 17, 26$6.50Jun 22, 26$7.08Jun 24, 26$6.74Jun 26, 26$7.29Jul 2, 26$7.92
$3.5752-week range$8.61
Loading valuation history…

Fundamentals

Key fundamentals

$89.5M

Market cap

-50.1%

Revenue growth (YoY)

92.0%

Gross margin

-$65.9M

Free cash flow (USD)

-$86.8M

Net debt

Net cash position

87.7%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$7.0MFY 2017$6.5MFY 2018$10.9MFY 2019$22.2MFY 2020$24.3MFY 2021$115.5MFY 2022$25.1MFY 2023$48.7MFY 2024$68.7MFY 2025$34.3M
$7M$34.3M

Free cash flow by year

2016 → 2025

FY 2016$90.2MFY 2017$-29.7MFY 2018$-67.4MFY 2019$-98.3MFY 2020$-92.4MFY 2021$-16.7MFY 2022$-49.1MFY 2023$-86.4MFY 2024$-58.7MFY 2025$-65.9M
$90.2M-$65.9M

Gross margin by year

2021 → 2025

FY 2021100.0%FY 2022100.0%FY 2023100.0%FY 2024100.0%FY 202592.0%
100.0%92.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 5, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventClinical Trial UpdateJul 1, 2026Filing
  • 8-K eventLoan Agreement AmendmentJun 16, 2026Filing
  • 8-K eventClinical Data AnnouncementMay 27, 2026Filing
  • 8-K eventIncentive Award Plan UpdateMay 26, 2026Filing
  • 8-K eventEarnings ReleaseMay 5, 2026Filing
  • Quarterly report10-Q FiledMay 5, 2026Filing

Questions

Frequently asked questions

What is Precision BioSciences, Inc.'s market cap?

Precision BioSciences, Inc. (DTIL) has a market capitalization of $89.5M.

What is DTIL's P/E ratio?

A meaningful P/E ratio is not available for DTIL — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is DTIL's price-to-book (P/B) ratio?

DTIL trades at 0.97 times book value per share.

Are insiders buying DTIL stock?

SEC Form 4 filings show no open-market insider buys at Precision BioSciences, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

ICCC

ImmuCell Corporation

$89.6M

NRXS

NeurAxis, Inc.

$89.9M

ANIX

Anixa Biosciences, Inc.

$92.2M

VTVT

vTv Therapeutics Inc.

$86.7M

COYA

Coya Therapeutics, Inc.

$86.3M

FBIO

Fortress Biotech, Inc.

$93.3M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.